FHIR Release 3 (STU) CI-Build

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0 . For a full list Continuous Integration Build of available versions, see FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0310.xml

Example MedicationAdministration/medadmin0310 (XML)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Ballot Standards Status : Informative Compartments : Device , Encounter , Group , Patient , Practitioner , RelatedPerson

Raw XML ( canonical form ) Jump past Narrative + also see XML Format Specification )

Oral Chemotherapy - Myleran (id = "medadmin0310")

(Details : {http://hl7.org/fhir/sid/ndc code '76388-713-25' = '76388-713-25', given as 'Myleran 2mg tablet, film coated'})6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL(Details : {SNOMED CT code '26643006' = 'Oral route', given as 'Oral route (qualifier value)'}) 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL 
<?xml version="1.0" encoding="UTF-8"?>

<MedicationAdministration xmlns="http://hl7.org/fhir">  <id value="medadmin0310"/>   <contained>     <Medication>       <id value="med0304"/>       <code>         <coding>           <system value="http://hl7.org/fhir/sid/ndc"/>           <code value="76388-713-25"/>           <display value="MYLERAN, 25 TABLET, FILM COATED in 1 BOTTLE (76388-713-25) (package)"/>         </coding>         <text value="Myleran 2mg tablet, film coated"/>       </code>     </Medication>   </contained>   <status value="completed"/>   <medication>     <reference>       <reference value="#med0304"/>     </reference>   </medication>   <subject>     <reference value="Patient/pat1"/>     <display value="Donald Duck"/>   </subject>   <occurrencePeriod>     <start value="2015-01-15T22:03:00+01:00"/>     <end value="2015-01-16T02:03:00+01:00"/>   </occurrencePeriod>   <performer>     <actor>       <reference>         <reference value="Practitioner/f007"/>         <display value="Patrick Pump"/>       </reference>     </actor>   </performer>   <request>     <reference value="MedicationRequest/medrx0306"/>   </request>   <dosage>     <text value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC)

     count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater
     than 50,000/µL"/> 
    <route>       <coding>         <system value="http://snomed.info/sct"/>         <code value="26643006"/>         <display value="Oral route (qualifier value)"/>       </coding>     </route>     <dose>       <value value="6"/>       <unit value="mg"/>       <system value="http://unitsofmeasure.org"/>       <code value="mg"/>     </dose>   </dosage> 


</

MedicationAdministration

>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.